EBOS GROUP LIMITED (EBO)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

EBO - EBOS GROUP LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$34.42

07 Dec
2021

0.120

OPEN

$34.40

0.35%

HIGH

$34.42

1,855

LOW

$33.88

TARGET
$34.25 -0.5% downside
Franking for last dividend paid out: 96%
OTHER COMPANIES IN THE SAME SECTOR
SLA . CAJ . GXL . HSO . MPL . MVF . NHF . HLS . RHC . SHL . VRT . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . BMT . NVL . AHX . ALC . ACL .
FNARENA'S MARKET CONSENSUS FORECASTS
EBO: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx 113.2 125.2 xxx
DPS (cps) xxx 46.0 90.8 xxx
EPS Growth xxx 12.5% 10.6% xxx
DPS Growth xxx 15.0% 97.4% xxx
PE Ratio xxx N/A 27.7 xxx
Dividend Yield xxx N/A 2.6% xxx
Div Pay Ratio(%) xxx 40.6% 72.5% xxx

Dividend yield today if purchased 3 years ago: 2.19%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.26

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 09/09 - ex-div 38.8c (franking 96%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx113.2
DPS All xxxxxxxxxxxxxxx86.0
Sales/Revenue xxxxxxxxxxxxxxx9,202.9 M
Book Value Per Share xxxxxxxxxxxxxxx859.5
Net Operating Cash Flow xxxxxxxxxxxxxxx298.3 M
Net Profit Margin xxxxxxxxxxxxxxx2.01 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Capital Employed xxxxxxxxxxxxxxx13.59 %
Return on Invested Capital xxxxxxxxxxxxxxx9.80 %
Return on Assets xxxxxxxxxxxxxxx4.82 %
Return on Equity xxxxxxxxxxxxxxx13.59 %
Return on Total Capital xxxxxxxxxxxxxxx13.68 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx96.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

1

xxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx xx xxxxxxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

03/09/2021

3

Downgrade to Hold from Add

$34.50

0.23%

Morgans sees potential for further sales growth and margin expansion after the acquisition announcement of Sentry Medical, a designer, marketer and distributor of medical consumables. The target rises to $34.50 from $31.68, despite no changes to near-term forecasts.

Due to recent share price strength, the analyst pulls back the rating to Hold from Add and awaits a better entry point.

FORECAST
Morgans forecasts a full year FY22 dividend of 88.00 cents and EPS of 126.00 cents.
Morgans forecasts a full year FY23 dividend of 93.00 cents and EPS of 136.00 cents.

Macquarie

xx/xx/xxxx

1

xxxxxxx xx xxxxxxxxxx xxxx xxxxxxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

xx/xx/xxxx

3

xxxxxxxxxx xx xxxxxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EBO STOCK CHART